Activation of the PI3K/AKT pathway by microRNA-22 induces the proliferation of CLL cells, which can be reversed by inhibiting the PI3K-Δγ signaling pathway using IPI-145 (114, 115). Here, AKT1 is linked to B-cell chronic lymphocytic leukemia.